Where are you?
To give you the most accurate information about our products and what we can do for you, we need to direct you to the right site.
USA
International
Media and Investors Resources
Press Release, 23 November 2022
Kuros Biosciences Completes Enrollment of Randomized Stage of Phase 2 Trial for Fibrin-PTH
Press Release, 2 November 2022
Kuros Biosciences completes enrolment in Level 1 clinical study of MagnetOs Granules
Press Release, 26 October 2022
Kuros reports 73% increase in MagnetOs sales in first nine months of 2022
Press Release, 19 October 2022
Kuros Biosciences awarded 2022 Spine Technology Award for MagnetOs Flex Matrix by Orthopedics This Week
Press Release, 11 October 2022
Kuros Biosciences to present positive clinical data for MagnetOs at NASS 2022 Annual Meeting
Press Release, 11 October 2022
Kuros Biosciences to present positive clinical data for MagnetOs at NASS 2022 Annual Meeting
media-investors
2022